Mike Kluse, director of the U.S. Department of Energy’s Pacific Northwest National Laboratory and senior vice president at Battelle, has announced his plans to retire. Kluse has been that director of the laboratory since 2007 and during tenure has grown its business from $750 million to more than one billion, as well as securing funding for the construction of seven new buildings on the campus.
Scientists at Battelle have developed a tiny bead...
A Massachusetts startup has signed a license agreement with Battelle to commercialize battery...
At Battelle, supporting America’s military personnel is woven into the fabric of its business. In that pursuit, a team consisting of Battelle, NxStage Medical Inc. and Aethlon Medical has won a contract from DARPA to develop an innovative, new medical device that may save the lives of soldiers—and civilians as well—by treating sepsis.
An injection of carbon dioxide has begun at a site in southeastern Washington to test deep geologic storage. Battelle researchers based at Pacific Northwest National Laboratory are placing 1,000 tons of the gas one-half mile underground to see if the greenhouse gas can be stored safely and permanently in ancient basalt flows.
As many as 10% of combat wounds result in life threatening infections that ultimately lead to septicemia and/or sepsis. Battelle, in partnership with NxStage Medical Inc. and Aethlon Medical, has won a nearly $23 million contract from DARPA to develop a new medical device that would holistically treat for sepsis by removing blood and cleaning it in a manner similar to dialysis.
Proteus, a new class of underwater vehicle that is unique in its ability to operate in either manned or autonomous mode, has been recognized as one of the best technical products of the year by R&D Magazine. With large payload capacity, long range, high endurance and advanced autonomous behaviors, Proteus provides capabilities unavailable in other unmanned underwater vehicles (UUVs).
A Battelle study released by United for Medical Research illustrates the genetics and genomics industry’s impact on the U.S. economy has reached nearly a trillion dollars. The study is based on new data collected over the previous two years, and represents an update to the highly cited Battelle 2011 report tracking the growth of the industry and its links to the federally funded Human Genome Project (HGP).
Research conducted with a large new battery unveiled in Oregon will help make the Northwest's and the nation's electric system smarter and more efficient, officials said at a ribbon-cutting ceremony. Portland General Electric's 5-MW, lithium-ion energy storage system was shared with the public Friday at the utility's Salem Smart Power Center in South Salem, Ore.
An enhanced battery technology that can potentially reduce the time it takes to charge cell phones, electric vehicles, and other battery-powered devices from hours to minutes is the subject of a commercial license agreement between Battelle and Vorbeck Materials Corp. The agreement will allow Vorbeck to bring lithium batteries incorporating Vor-X graphene technology to market for use in consumer portable electronic and medical devices, tools, and electric vehicles.
The U.S. Department of Energy's Pacific Northwest National Laboratory (PNNL) and Calico Energy Services announced that Calico has licensed a portfolio of advanced energy management intellectual property developed by PNNL. The technology was licensed by Battelle, which manages PNNL for the DOE.
Global R&D spending is forecast to grow by 3.7%, or $53.7 billion in 2013 to $1.496 trillion, according to research by analysts at Battelle, Columbus, Ohio, and R&D Magazine, Rockaway, N.J. The largest share of this increase, $22.9 billion, is expected to come from China, which continues its decade-long annual double digit increases in R&D investments.
The watchword heading into 2013 is uncertainty, and the effect on the U.S. research and development enterprise is more unclear than ever. The current economic condition and uneasy prospects for the future combined with a federal government funding projection that could range anywhere from flat to significant declines have limited the prospects for 2013.
With significant fiscal debates ongoing, a detailed discussion of FY 2013 federal R&D funding would be of limited value at this time. Instead we highlight a few key issues and describe how the current budget will likely be developed. For an up-to-date analysis of federal R&D appropriations, we recommend the AAAS R&D Budget and Policy Program.
R&D is generally a long-term investment, building upon the results of previous years' expenditures, leading first to the generation of new knowledge through basic research and ultimately to products and services through applied research, development, and commercialization. These are considered to be functional impacts.
The amount of R&D funded by U.S. academia is forecast to increase by 2.1% in 2013 to $12.7 billion. The amount of R&D performed by U.S. academia (funded by all sources) is expected to increase by 0.4% to $66.6 billion. Both of these values generally are well below 3% or larger range in previous Global R&D Funding Forecasts.
In the following ten pages the Battelle/R&D Magazine team presents information on five key industry segments within the U.S. and global R&D enterprise. These five have been examined over the past two forecasts, allowing us to identify and interpret the underlying trends and drivers of these segments' R&D spending.
Increasing healthcare costs, aging populations, and rising prevalence of chronic diseases are among the factors that will continue to shape the direction of industrial life science R&D in 2013. Technology deployment in healthcare information technology and analytics will also have an increasing impact on research while contributing to efficiency and quality.
Information and communications technology (ICT) continues to evolve into various form factors, platforms, and system configurations. Its expanding applications base includes increasingly high-performance and cloud-based computing systems, a massive infrastructure of mobile communications, global networks of sensing systems, military and defense networks, Internet-based control systems, and many more.
Cost containment will influence aerospace, defense, and security (ADS) R&D, where industry investment is linked to government needs and funding. In the west, large new weapon system development programs will continue to give way to technologies that extend the life of extant platforms. In space-related research, budget constraints at NASA may stimulate additional new private sector investment in the U.S. and abroad.
Private-sector energy R&D covers a diverse portfolio of technologies related to electricity generation and use, exploration and extraction, efficiency, clean and sustainable fuels, and transportation. Energy innovation can be influenced by public-sector policies, research, and funding which complements and stimulates industrial R&D.
Chemicals and advanced materials comprise a broad sector that includes chemicals, catalysts, polymers, metals, ceramics, and nanomaterials—from products sold by the trainload to those that cost hundreds of dollars per gram. It is an innovation-intensive business: for example, the U.S. chemical industry is responsible for over one tenth of all patents filed in the United States.
R&D investments have become highly competitive between nations, with each looking to outspend the others to maintain a competitive edge. This internationalization of R&D now pits the U.S., China, Japan, and the EU against each other to develop breakthrough technologies that can be developed into marketable products that can build their country's export trade.
While strictly categorized as an emerging nation by the IMF, the Federative Republic of Brazil is the world’s fifth largest country in geographic size and population and sixth overall in gross domestic product (GDP). By 2040, Brazil’s economy is forecast to be the fourth largest in the world, behind China, the U.S., and India.
Gross domestic expenditures on R&D (GERD) in the Russian Federation nearly doubled (at constant prices) from 1998 to 2008, one of the highest growth rates at that time. Russia's 2013 R&D is forecast to grow to $38.5 billion, a 4.0% increase over the $37 billion spent in 2012.
India has averaged greater than 7% annual GDP growth since 1997, but the current outlook is unusually uncertain. Real GDP growth for 2012 is expected to be close to 5%, according to the International Monetary Fund (IMF). The IMF's GDP growth forecast for 2013 increases to nearly 6% following various recent reforms. 2013 economic growth is expected to yield R&D spending growth of about 12.2% over that spent in 2012.
Continuing the trend it established more than a decade ago, China's commitment to R&D is expected to increase 11.6% in 2013, following an 11.3% increase in 2012. China's R&D is now 52% of that expected to be spent by the U.S. in 2013, compared to 43% just two years ago.
Half of the Top 40 R&D spending countries in the world are in Europe, but they only account for 22.6% of the total global spending. Another 14 European countries increase that spending by $10.7 billion (23.4% of the global total). Over the past five years, Europe has continuously declined in its share of global R&D spending.
- Page 1